Not applicable.
This invention relates to devices and methods for treating urethral strictures.
Urethral strictures are caused by the growth of scar tissue typically following injury related-trauma and/or a bacterial infection. As the name implies, such scar tissue build-up narrows and thereby makes urination difficult and painful for an individual. In extreme cases, a urethral stricture may close the urethra and prevent an individual from urinating. Urinary retention may result in a medical emergency.
There are currently several methods available to treat urethral strictures. In one such method, the patient is first sedated. A set of progressively larger metal rods are then inserted into the urethra to gradually increase its size. Unfortunately, such a procedure can damage both healthy and diseased tissue, and such procedures are also typically painful despite the use of sedatives. Further still, a drainage catheter is often used after the procedure, in some cases for up to several days, to ensure urine flow is not obstructed by inflammation caused by the procedure.
Another method for treating urethral strictures involves surgically repairing the damaged section of the urethra. This includes using small endoscope attached to a blade for cutting away scar tissue. However, such a procedure is technically challenging and may fail due to excessive urethral bleeding.
Urethroplasty is yet another method for treating urethral strictures. This procedure involves making a large incision to remove scar tissue followed by realignment of native tissues or grafting a biocompatible material. Unfortunately, urethroplasty requires significant operating time and inpatient treatment. Patients must also use a urinary catheter for weeks after the procedure and may often experience significant pain and discomfort during that period. Furthermore, these procedures require skilled anesthesia and surgical personnel, and as such, may cost up to several thousand dollars.
Considering the limitations of the previous devices and methods, new devices and methods for treating urethral strictures are needed. Such devices and methods advantageously reduce patient discomfort, permit urine flow during a procedure, reduce urethral inflammation compared to other treatment devices and methods, reduce the need for patient sedation, and/or increase the feasibility of treating urethral strictures outside of hospital settings.
In one aspect, the present invention provides a stricture treatment and drainage catheter comprising a drainage lumen having a first end and a second end. The first end defines a drainage inlet and the second end defines a drainage outlet. The catheter further comprises a stricture dilator supported by the drainage lumen between the second end and the first end. The stricture dilator is changeable between a collapsed position and a plurality of expanded positions. An expansion indicator operatively connects to the stricture dilator and displays an indication if the stricture dilator is in one of the plurality of expanded positions.
In some embodiments, the expansion indicator displays the expanded size of the stricture dilator as a French scale number. Furthermore, in some embodiments, the stricture dilator comprises a radially expanding mandrel having a plurality of mandrel legs. Each of the mandrel legs has a second end and a first end, and each of the mandrel legs bows outwardly between the second end and the first end in each of the plurality of expanded positions. In other embodiments, the stricture dilator comprises an inflatable stricture dilator that defines a second internal chamber, and the second internal chamber receives a second substance to expand the inflatable stricture dilator.
The foregoing and advantages of the invention will appear in the detailed description which follows. In the description, reference is made to the accompanying drawings which illustrate a preferred embodiment of the invention.
The invention will hereafter be described with reference to the accompanying drawings, wherein like reference numerals denote like elements, and:
Referring first to
Still referring to
The drainage lumen 112 may comprise any of a variety of materials commonly associated with drainage catheters, such as flexible polymers. However, other materials or combinations of materials may also be used without departing from the scope of the invention.
In addition to drainage components, the catheter 110 also includes components to anchor or prevent the device from being unintentionally withdrawn from the urethra. Specifically, the catheter 110 includes an inflatable anchor 124 (e.g., an expandable polymer balloon) proximate the first end 114 of the drainage lumen 112. The inflatable anchor 124 defines an internal anchor chamber 126 (
The inflatable anchor 124 is supported by a second or anchoring lumen 128 disposed about the drainage lumen 112. The anchoring lumen 128 is spaced apart from the drainage lumen 112 and thereby defines an anchoring passageway 130 (
The inflatable anchor 124, the anchoring lumen 128, and the anchor port 132 may comprise any of a variety of materials commonly associated with drainage catheters, such as flexible polymers. However, other materials or combinations of materials may also be used without departing from the scope of the invention.
As the name implies, the stricture treatment and drainage catheter 110 also includes components that engage and increase the size of the urethra at a urethral stricture. Specifically, the device 110 includes a third or dilator lumen 134 disposed about the anchoring lumen 128. The dilator lumen 134 supports a stricture dilator that is expandable to engage and relieve a urethral stricture. In the embodiment shown in
In the expanded positions, the mandrel legs 138 define a larger overall size (i.e., the outer perimeter defined by the outermost points of the mandrel legs 138) than in the collapsed position. Stated another way, each of the mandrel legs 138 has a first end that is movable along the dilator lumen 134 and a second end that is fixed to the dilator lumen 134. In the expanded positions, the mandrel legs 138 bow outwardly between the first end and the second end to define a larger overall size than when the device 110 is in the collapsed position.
The mandrel legs 138 may comprise any of a variety of flexible and fatigue-resistant materials, such as silicone, latex, polyethylene, polytetrafluoroethylene TeflonĀ®), or the like. However, other materials or combinations of materials may also be used without departing from the scope of the invention.
The mandrel legs 138 operatively connect to an expansion control positioned toward the second end of the device 110. In the embodiment shown in
In its simplest form, the expansion indicator 142 is a rotatable wheel that displays the French scale number of the overall expanded size of the mandrel legs 138. In other embodiments, the expansion indicator 142 may be a digital display. Regardless of the specific form of the expansion indicator 142, the dial 140 and the mandrel legs 138 may be connected such that a single turn or an increment of a turn of the dial 140 provides a discrete size change of the overall size of the mandrel legs 138. For example, one turn or one-half turn of the dial 140 may cause the overall size of the mandrels legs 138 to change by one French scale number. In any case, the expansion indicator 142 permits medical personnel to precisely control the overall size of the mandrel legs 138. As such, the overall size of the mandrel legs 138 can be adjusted for urethral strictures of varying severity or in view of other factors, such as subject age and overall wellness. These considerations can reduce subject discomfort and increase the effectiveness of treatment using the device 110.
Of course, the device 110 may vary from the above description without departing from the scope of the invention. For example and as described above, the stricture dilator is supported by a dilator lumen 134. In some embodiments, the dilator lumen 134 may be detachably supported by the anchoring lumen 128. As such, the dilator lumen 134 and the stricture dilator may be detached from the anchoring lumen 128 after use. The dilator lumen 134 and the stricture dilator could then be sterilized for subsequent use with another anchoring lumen 128 and drainage lumen 112. As another example and referring to
Referring now to
As shown most clearly in
As shown schematically in
In some cases, the delivery apparatus 252 may be the same apparatus that delivers the anchoring substance to the inflatable anchor 224. In these cases, the system shown in
Referring now to
Regardless of the specific construction of the stricture treatment and drainage catheter, the device 110 is preferably used as follows. The second and third embodiments of the device 210 and 310 are also preferably used as follows, although only reference numbers of the first embodiment of the device 110 are used for simplicity. First, if necessary, the dilator lumen 134 is connected to the anchoring lumen 128. Next, the device 110 is inserted into the subject's urethra such that the drainage inlet 116 and the inflatable anchor 124 are disposed within the bladder and the stricture dilator is disposed adjacent the urethral stricture. The device 110 is then connected to a delivery apparatus to provide the anchoring substance to the inflatable anchor 124 and thereby expand the anchor 124. Next, the stricture dilator is moved to one of the expanded positions by rotating the dial 140 or providing the dilating substance to the device. This expansion causes the stricture dilator to contact and relieve a urethral stricture.
The above method may further include additional and optional steps. For example, the overall size of the stricture dilator may be gradually increased over a predetermined time period (e.g., several days). In some embodiments, this may be controlled automatically by the processor 254. As another example, the stricture dilator may be expanded to deploy a stent that engages and treats a urethral stricture. The device may then be removed while the stent remains in place in the urethra.
From the above description, it should be apparent that all of the embodiments of the stricture treatment and drainage catheter provide several common advantages. For example, the device permits urine flow during a procedure due to the presence of the drainage lumen. As another example, the device reduces subject discomfort and urethral inflammation compared to other treatment devices because the stricture dilator expands radially to engage and treat a stricture. That is, in contrast to the previous devices described above, the stricture treatment and drainage catheter does not traumatically engage both diseased and healthy urethral tissue during insertion. This aspect of the device also reduces the need for subject sedation. As yet another example, the expansion indicator permits medical personnel to precisely control the expanded size of the stricture dilator, thereby increasing the effectiveness of treatment using the device. Furthermore, in some ways the device is used in a similar manner compared to a drainage catheter, and the expansion indicator facilitates ease of use. As such, methods for using the device are relatively simple compared to the previous stricture treatment methods described above, and therefore the device facilitates treatment of urethral strictures outside of hospital settings.
Furthermore, the embodiments of the stricture treatment and drainage catheter also provide different advantages compared to one another. For example, the device 110 does not require delivery apparatus use (i.e., pump use) after the inflatable anchor 124 is initially expanded. Therefore the pump can be disconnected from the catheter device 110 after the inflatable anchor 124 is initially expanded. A valve or the like would be needed to seal the anchoring substance within the anchoring lumen 128 and the inflatable anchor 124, but nevertheless the pump could be disconnected and put to other uses. Furthermore, the mandrel legs 138 provide relatively large forces for relieving urethral strictures compared to their small size. Other means for providing these forces are typically much larger. As another example, the devices 210 and 310 could be supplied a liquid, gas, or hydrogel from the same pump that delivers the substance to the inflatable anchor. As such, various aspects of treatment could be controlled from the user interface of the pump after the device is inserted into the subject's urethra.
A preferred embodiment of the invention has been described in considerable detail. Many modifications and variations to the preferred embodiment described will be apparent to a person of ordinary skill in the art. Therefore, the invention should not be limited to the embodiment described, but should be defined by the claims that follow.
This application claims the benefit of U.S. Provisional Patent Application No. 61/354,300 filed Jun. 14, 2010, the disclosure of which is hereby incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US11/40121 | 6/13/2011 | WO | 00 | 2/22/2013 |
Number | Date | Country | |
---|---|---|---|
61354300 | Jun 2010 | US |